Clover Health Investments Free Cash Flow 2020-2024 | CLOV

Clover Health Investments free cash flow from 2020 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Clover Health Investments Annual Free Cash Flow
2023 -116.46
2022 -290.82
2021 -283.05
2020 -119.19
2019 -159.90
Clover Health Investments Quarterly Free Cash Flow
2024-09-30 119.44
2024-06-30 69.85
2024-03-31 25.49
2023-12-31 -116.46
2023-09-30 112.58
2023-06-30 131.60
2023-03-31 78.78
2022-12-31 -290.82
2022-09-30 4.85
2022-06-30 -96.54
2022-03-31 -57.20
2021-12-31 -283.05
2021-09-30 -202.64
2021-06-30 -157.31
2021-03-31 -92.97
2020-12-31 -119.19
2020-09-30 -59.22
2020-06-30 -24.41
2020-03-31 -37.42
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.200B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.870B 55.80
Tempus AI (TEM) United States $9.036B 0.00
Hims & Hers Health (HIMS) United States $8.145B 207.11
Inspire Medical Systems (INSP) United States $5.799B 180.84
IRhythm Technologies (IRTC) United States $3.407B 0.00
Privia Health (PRVA) United States $2.742B 228.50
Enovis (ENOV) United States $2.671B 17.80
Azenta (AZTA) United States $2.470B 131.83
Omnicell (OMCL) United States $2.084B 68.17
Schrodinger (SDGR) United States $1.827B 0.00
10x Genomics (TXG) United States $1.816B 0.00
Phreesia (PHR) United States $1.654B 0.00
Butterfly Network (BFLY) United States $0.850B 0.00
Standard BioTools (LAB) United States $0.577B 0.00
Talkspace (TALK) United States $0.524B 0.00
Fulgent Genetics (FLGT) United States $0.509B 0.00
TruBridge (TBRG) United States $0.370B 107.91
Nyxoah SA (NYXH) Belgium $0.368B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.229B 0.00
Pulmonx (LUNG) United States $0.224B 0.00
American Well (AMWL) United States $0.165B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
EUDA Health Holdings (EUDA) Singapore $0.087B 0.00
P3 Health Partners (PIII) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
CareCloud (CCLD) United States $0.056B 0.00
111 (YI) China $0.050B 0.00
SHL Telemedicine (SHLT) Israel $0.047B 0.00
Outset Medical (OM) United States $0.043B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00